InvestorsHub Logo
Followers 11
Posts 764
Boards Moderated 0
Alias Born 04/19/2016

Re: Bearcat10 post# 60340

Tuesday, 11/05/2019 5:45:36 PM

Tuesday, November 05, 2019 5:45:36 PM

Post# of 82977
It will only be a bloodbath if people give up their shares. I own a boatload and will not be selling one. The quarter was disappointing, but annual revenue projections of $55-57 MM. Not shabby. And you don't think that Stuart Tomc is working on multiple fronts for new distribution? And people have been asking for a senior marketing person, and it looks like they just hired one. Ask yourself how you compete with a store front who is receiving free product?

Do you get the sense that Duffy MacKay is doing a lot of out front and behind the scenes work with FDA? Oh yeah, and he knows them well, having been a leader in that space for 10 plus years with CRN.

For the first time we got a lot more clarity about the drug program. Starting clinical trials in the first half of 2020. That is huge. The regulatory environment is a bit more friendly in Europe, I can tell you that from my experience in pharma.

I would guess that Tomc and company might be looking for international opportunities to sell product.

So big picture, down 7% in intense competition. We're still the market leader. We have a plan. Multiple divisions. Expanded capability. New leaders. Our day will come.

Don't help by giving away your shares.

MT
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVSI News